Skip to main content
Caplight Logo









Evogenom Oy

Evogenom Oy

Private
JyväskyläHealthcare & Life Scienceshttps://evogenom.com/

Last Round

Early Funding

Oct 8, 2024

Company Overview

Evogenom Oy is a biotechnology company that provides direct-to-consumer genetic testing services and personalized wellness recommendations through its mobile application and AI-powered coaching platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, Sports & Fitness

Business Model

B2C

Customer Profile

Hardware + Subscription, Usage-Based SaaS

AI Layer

Application

Keywords

genetic testingDNA testpersonalized wellnessbiohackingAI wellness coachat-home DNA kitnutrigenomicsprecision medicinefitness optimizationdirect-to-consumerD2Chabit trackinghealth techbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evogenom Oy Comparables

Compare Evogenom Oy with similar companies based on industry and business-model similarity.

Evogenom Oy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FitnessGenes
82%
Muhdo Health
81%
GenoPalate, Inc.
81%

Evogenom Oy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 8, 2024

Key People

Founding team and executive leadership

Sofia Lund

Founder, CEO

Founding Team

Evogenom Oy Investors

Notable investors and investment history

Evogenom Oy investors
InvestorRounds
Trind VCEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2025

    Monthly visitors increased 135% MoM, reaching 4.4K.

  • Oct 8, 2024

    Trind VC led the early funding round.

Evogenom Oy Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Evogenom Oy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evogenom Oy's valuation, stock price, and market status.

Firmographic Details

HeadquartersJyväskylä
Employee Range11
Year Founded2016
Last FundingOct 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?